Unitedhealth (UNH) Cash & Equivalents (2009 - 2026)

Unitedhealth (UNH) has 18 years of Cash & Equivalents data on file, last reported at $28.0 billion in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $28.0 billion, down 8.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $28.0 billion (down 8.84% YoY), and the FY2025 annual result was $24.4 billion, down 3.74% from the prior year.
• Cash & Equivalents climbed to $28.0 billion in Q1 2026 per UNH's latest filing, from $24.4 billion in the prior quarter.
• Over five years, Cash & Equivalents peaked at $41.9 billion in Q1 2023 and troughed at $266.0 million in Q4 2022.
• A 5-year average of $27.3 billion and a median of $28.0 billion in 2026 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2022 and 2024: Cash & Equivalents slumped 87.72% in 2022, then soared 3161.86% in 2024.
• A 5-year view of Cash & Equivalents shows it stood at $266.0 million in 2022, then soared by 191.73% to $776.0 million in 2023, then jumped by 3161.86% to $25.3 billion in 2024, then fell by 3.74% to $24.4 billion in 2025, then increased by 14.92% to $28.0 billion in 2026.
• Business Quant data shows UNH's Cash & Equivalents at $28.0 billion in Q1 2026, $24.4 billion in Q4 2025, and $27.2 billion in Q3 2025.